The previous Paralympic logo incorporated the Tae-Geuk, which is a traditional Korean decorative motif. According to oriental philosophy, Tae-Geuk refers to the ultimate reality from which all things ...
Chris Rose of ProStrakan offers advice on selling in the pharmaceutical industry. The 80's and 90's spawned a host of selling models and most of us in the pharma business have been trained to use ...
The best logo maker helps you craft the right branding for your business - even if you've never designed a logo before. Our team of expert reviewers have tested the best free logo makers and the ...
Revenue forecast for the pharmaceutical market in the Asia-Pacific region in 2023, by country (in billion U.S. dollars) Characteristic Revenue in billion U.S. dollars ...
Students acquire in- depth knowledge in various fields of Pharmaceutical Sciences and gain scientific skills and insight into drug development prozess. Compulsory subjects, electives and a research ...
Pharmaceutical market revenue in the Asia-Pacific region from 2019 to 2023, with forecasts to 2028, by segment (in billion U.S. dollars) ...
Medicinal chemists are known to explore new areas and work to improve human health and reduce suffering. A good imagination and persistence are required. Medicinal and pharmaceutical chemists apply ...
Alexion Pharmaceuticals, Inc. (Alexion) is a biopharmaceutical company focused on serving patients with severe and ultra-rare disorders through the development and commercialization of life ...
A Reddit thread started Thursday titled, "What's wrong with the Facebook logo?" shows a blue lowercase "f" on a black background instead of a blue background with a white "f." Some users who have ...
Questcor Pharmaceuticals, Inc. operates as a biopharmaceutical company which focuses on the treatment of patients with serious, difficult-to-treat autoimmune and inflammatory disorders.
M.D. Ph.D., 50 Northern Ave, Boston, Massachusetts 02210, Chief Scientific Officer, Executive Vice President, Global Research Vertex Pharmaceuticals Incorporated ...
Amid shifting operating dynamics in recent years, demands for external expertise have fluctuated—leaving those arrangements that mix innovation and agility likely to win out in pharma decision-making.